Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1 : An Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines study
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved..
OBJECTIVE: To assess recurrence according to the type of surgery for primary hyperparathyroidism (pHPT) in multiple endocrine neoplasia type 1 ( MEN1 ) patients and to identify the risk factors for recurrence after the initial surgery.
BACKGROUND: In MEN1 patients, pHPT is multiglandular, and the optimal extent of initial parathyroid resection influences the risk of recurrence.
METHODS: MEN1 patients who underwent initial surgery for pHPT between 1990 and 2019 were included. Persistence and recurrence rates after less than subtotal parathyroidectomy (LTSP) and subtotal parathyroidectomy (STP) were analyzed. Patients with total parathyroidectomy with reimplantation were excluded.
RESULTS: Five hundred seventeen patients underwent their first surgery for pHPT: 178 had LTSP (34.4%) and 339 STP (65.6%). The recurrence rate was significantly higher after LTSP (68.5%) than STP (45%) ( P < 0.001). The median time to recurrence after pHPT surgery was significantly shorter after LTSP than after STP: 4.25 (1.2-7.1) versus 7.2 (3.9-10.1) years ( P < 0.001). A mutation in exon 10 was an independent risk factor of recurrence after STP (odds ratio = 2.19; 95% CI: 1.31; 3.69; P = 0.003). The 5 and 10-year recurrent pHPT probabilities were significantly higher in patients after LTSP with a mutation in exon 10 (37% and 79% vs 30% and 61%; P = 0.016).
CONCLUSIONS: Persistence, recurrence of pHPT, and reoperation rate are significantly lower after STP than LTSP in MEN1 patients. Genotype seems to be associated with the recurrence of pHPT. A mutation in exon 10 is an independent risk factor for recurrence after STP, and LTSP may not be recommended when exon 10 is mutated.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:279 |
|---|---|
| Enthalten in: |
Annals of surgery - 279(2024), 2 vom: 01. Feb., Seite 340-345 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Santucci, Nicolas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.01.2024 Date Revised 01.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/SLA.0000000000005980 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358911419 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358911419 | ||
| 003 | DE-627 | ||
| 005 | 20240201231908.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/SLA.0000000000005980 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1277.xml |
| 035 | |a (DE-627)NLM358911419 | ||
| 035 | |a (NLM)37389888 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Santucci, Nicolas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1 |b An Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2024 | ||
| 500 | |a Date Revised 01.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a OBJECTIVE: To assess recurrence according to the type of surgery for primary hyperparathyroidism (pHPT) in multiple endocrine neoplasia type 1 ( MEN1 ) patients and to identify the risk factors for recurrence after the initial surgery | ||
| 520 | |a BACKGROUND: In MEN1 patients, pHPT is multiglandular, and the optimal extent of initial parathyroid resection influences the risk of recurrence | ||
| 520 | |a METHODS: MEN1 patients who underwent initial surgery for pHPT between 1990 and 2019 were included. Persistence and recurrence rates after less than subtotal parathyroidectomy (LTSP) and subtotal parathyroidectomy (STP) were analyzed. Patients with total parathyroidectomy with reimplantation were excluded | ||
| 520 | |a RESULTS: Five hundred seventeen patients underwent their first surgery for pHPT: 178 had LTSP (34.4%) and 339 STP (65.6%). The recurrence rate was significantly higher after LTSP (68.5%) than STP (45%) ( P < 0.001). The median time to recurrence after pHPT surgery was significantly shorter after LTSP than after STP: 4.25 (1.2-7.1) versus 7.2 (3.9-10.1) years ( P < 0.001). A mutation in exon 10 was an independent risk factor of recurrence after STP (odds ratio = 2.19; 95% CI: 1.31; 3.69; P = 0.003). The 5 and 10-year recurrent pHPT probabilities were significantly higher in patients after LTSP with a mutation in exon 10 (37% and 79% vs 30% and 61%; P = 0.016) | ||
| 520 | |a CONCLUSIONS: Persistence, recurrence of pHPT, and reoperation rate are significantly lower after STP than LTSP in MEN1 patients. Genotype seems to be associated with the recurrence of pHPT. A mutation in exon 10 is an independent risk factor for recurrence after STP, and LTSP may not be recommended when exon 10 is mutated | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Ksiazek, Elea |e verfasserin |4 aut | |
| 700 | 1 | |a Pattou, François |e verfasserin |4 aut | |
| 700 | 1 | |a Baud, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Mirallié, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Frey, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Trésallet, Christophe |e verfasserin |4 aut | |
| 700 | 1 | |a Sébag, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Guérin, Carole |e verfasserin |4 aut | |
| 700 | 1 | |a Mathonnet, Muriel |e verfasserin |4 aut | |
| 700 | 1 | |a Christou, Niki |e verfasserin |4 aut | |
| 700 | 1 | |a Donatini, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Brunaud, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Gaujoux, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Ménégaux, Fabrice |e verfasserin |4 aut | |
| 700 | 1 | |a Najah, Haythem |e verfasserin |4 aut | |
| 700 | 1 | |a Binquet, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Goudet, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Lifante, Jean-Christophe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgery |d 1885 |g 279(2024), 2 vom: 01. Feb., Seite 340-345 |w (DE-627)NLM000026654 |x 1528-1140 |7 nnns |
| 773 | 1 | 8 | |g volume:279 |g year:2024 |g number:2 |g day:01 |g month:02 |g pages:340-345 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/SLA.0000000000005980 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 279 |j 2024 |e 2 |b 01 |c 02 |h 340-345 | ||